US 7,569,711 B2
	Enone cancer therapeutics
Bruce Ganem, Ithaca, N.Y. (US); Donald J. Creighton, Baltimore, Md. (US); Diana S. Hamilton, Catonsville, Md. (US); and Zhebo Ding, Ithaca, N.Y. (US)
Assigned to Cornell Univeristy, Ithaca, N.Y. (US)
Filed on Dec. 07, 2004, as Appl. No. 11/6,132.
Application 11/006132 is a continuation of application No. 10/098834, filed on Mar. 15, 2002, abandoned.
Prior Publication US 2005/0233975 A1, Oct. 20, 2005
Int. Cl. C07C 59/147 (2006.01); C07C 59/185 (2006.01); C07C 315/00 (2006.01); C07C 317/00 (2006.01)

U.S. Cl. 554—118  [554/119; 568/37]

9 Claims

1. A compound of Formula 7 wherein X is a nucleophilic atom selected from the group consisting of S, N, and O and R is selected from the group consisting of COCH3, COC6H5 and CONHCH3; stereoisomers and positional isomers thereof.